S. Sartnurak

Effect of PF-04217329 a prodrug of a selective prostaglandin EP(2) agonist on intraocular pressure in preclinical models of glaucoma.

P. Wells, C. Toris, Chau Almaden, 2011, Experimental eye research.

Ocular pharmacokinetics and hypotensive activity of PF-04475270, an EP4 prostaglandin agonist in preclinical models.

P. Wells, E. Rui, Chau Almaden, 2009, Experimental eye research.

l‐Carnosine: multifunctional dipeptide buffer for sustained‐duration topical ophthalmic formulations

H. Gukasyan, H. Younis, Swita R. Singh, 2009, The Journal of pharmacy and pharmacology.

L-Carnosine: multifunctional dipeptide buffer for sustained-duration topical ophthalmic formulations.

H. Gukasyan, H. Younis, Swita R. Singh, 2009, The Journal of pharmacy and pharmacology.

Evaluation of solid dispersed particles for formulation of oral ibuprofen tablets

S. Sartnurak, 1985 .

The impact of low levels of amorphous material (<5%) on the blending characteristics of a direct compression formulation.

S. Sartnurak, L. Mackin, Iwan W. Thomas, 2002, International journal of pharmaceutics.